Olaparib Dose Escalating Trial in Patients Treated With Radiotherapy With or Without Daily Dose Cisplatin for Locally Advanced Non-small Cell Lung Carcinoma

Trial Profile

Olaparib Dose Escalating Trial in Patients Treated With Radiotherapy With or Without Daily Dose Cisplatin for Locally Advanced Non-small Cell Lung Carcinoma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Cisplatin; Olaparib
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 09 Oct 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2020 as reported by ClinicalTrials.gov record.
    • 09 Oct 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Nov 2017 as reported by ClinicalTrials.gov record.
    • 12 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top